English | 948 pages | ISBN-10: 0824705661 | PDF | 21.08 Mb
This state-of-the-art reference provides comprehensive coverage of the development of antisense oligonucleotides to inhibit cancer cells as well as those involved in infectious, inflammatory, and immune-mediated diseases-highlighting new tools and technologies in medicinal chemistry, RNA biochemistry, and molecular and cellular biology to produce new therapeutic compounds.
Presents previously unpublished data on the use of antisense technology to dissect pharmacological processes and confirm the roles of various genes!
Showcasing the benefits of antisense drug use, including reduced toxicity and earlier disease detection, Antisense Drug Technology discusses
novel formulations of antisense drugs
practical methods to design effective isotype selective inhibitors
molecular mechanisms of antisense drugs
mRNA as a current biological template
modern postreceptor binding mechanisms
With contributions by over 60 seasoned experts in the field and containing more than 3000 helpful references, tables, drawings, and photographs, Antisense Drug Technology is an illuminating source for organic, medicinal, and pharmaceutical chemists; biochemists; geneticists; hematologists; oncologists; molecular and cell biologists; virologists; immunologists; and medical school and graduate students in these disciplines.
(Buy premium account for maximum speed and resumming ability)